Search

everythinglearnresearchcommunity

for

Search:↓

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

The combination of encorafenib and binimetinib caused few skin issues.

Blocking certain brain processes reduces mating behavior in female rats.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Carriers of a specific gene mutation have subtle skin changes without visible symptoms.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

People with Down's syndrome are more likely to have syringomas.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

A 2-year-old boy with a rare brain malformation may have Gomez–López-Hernández syndrome.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

TRPV3 gene mutations cause Olmsted syndrome symptoms, but severity varies.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Prostaglandin treatments for glaucoma can cause rare eye area changes like eyelid deepening and fat pad prolapse.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

PRP injections help with carpal tunnel symptoms short-term, but more research is needed for long-term effects.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Most patients with dermatomyositis had skin rash and were treated with prednisolone and hydroxychloroquine.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Finasteride may help improve certain brain function issues linked to dopamine.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Erlotinib can cause excessive eyelash growth.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.